Procollagen type I carboxy-terminal proteinase:: A molecular target for reduction of myocardial fibrosis in patients with chronic heart failure?

被引：0
|
作者：
Lopez, B.
Gonzalez, A.
Beaumont, I.
Querejeta, R.
Sanchez, E.
Larman, M.
Diez, J.
机构：
[1] Ctr Appl Med Res, Pamplona, Spain
[2] Donostia Univ Hosp, San Sebastian, Spain
[3] Guipuzcoa Polyclin, San Sebastian, Spain
来源：
JOURNAL OF HYPERTENSION | 2007年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S177 / S178
页数：2
相关论文
共 50 条
  • [1] Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease
    Querejeta, R
    Varo, N
    López, B
    Larman, M
    Artiñano, E
    Etayo, JC
    Ubago, JLM
    Gutierrez-Stampa, M
    Emparanza, JI
    Gil, MJ
    Monreal, I
    Mindán, JP
    Diez, J
    CIRCULATION, 2000, 101 (14) : 1729 - 1735
  • [2] Circulating levels of procollagen type I carboxy-terminal propeptide reflect myocardial fibrosis
    Ferreira, Joao Pedro
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (06) : 945 - 946
  • [3] Is serum carboxy-terminal propeptide of procollagen type I levels (the indicator of myocardial fibrosis) higher in dipper hypertensive patients?
    Onrat, E
    Serteser, M
    Kaya, D
    Kahraman, A
    Koken, T
    Alpaslan, M
    Melek, M
    JOURNAL OF HYPERTENSION, 2004, 22 : S325 - S325
  • [4] Serum carboxy-terminal propeptide of human type I procollagen (PIP) is a marker of myocardial fibrosis in patients with early type 2 diabetes mellitus
    Ihm, S. -H.
    Youn, H. -J.
    Chang, K. -Y.
    Park, C. -S.
    Seung, K. -B.
    Kim, J. -H.
    Hong, S. -J.
    Choi, K. -B.
    EUROPEAN HEART JOURNAL, 2005, 26 : 490 - 490
  • [5] Circulating carboxy-terminal propeptide of type I procollagen is increased in rheumatic heart disease
    Banerjee, Tanima
    Mukherjee, Somaditya
    Biswas, Monodeep
    Dutta, Santanu
    Chatterjee, Shelly
    Ghosh, Sudip
    Pattari, Sanjib
    Nanda, Navin C.
    Bandyopadhyay, Arun
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 156 (01) : 117 - 119
  • [6] Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy
    Yang, Chengzhi
    Qiao, Shubin
    Song, Yunhu
    Liu, Yun
    Tang, Yajie
    Deng, Long
    Yuan, Jiansong
    Hu, Fenghuan
    Yang, Weixian
    CARDIOVASCULAR PATHOLOGY, 2019, 43
  • [7] Elevated carboxy-terminal peptide of procollagen type I in elderly patients with dastolic dysfunction
    Roongsritong, C
    Bradley, J
    Sutthiwan, P
    Simoni, J
    Arif, A
    Meyerrose, G
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2006, 331 (03): : 131 - 133
  • [8] Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure
    Stienen, Susan
    Ferreira, Joao Pedro
    Pitt, Bertram
    Cleland, John G.
    Pellicori, Pierpaolo
    Girerd, Nicolas
    Rossignol, Patrick
    Zannad, Faiez
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (05) : 901 - 903
  • [9] The Association Between Carboxy-Terminal Propeptide of Type I Procollagen and Aldosterone in Patients With Primary Aldosteronism
    Lin, Yen-Hung
    Wu, Vin-Cent
    Wu, Kwan-Dun
    AMERICAN JOURNAL OF HYPERTENSION, 2012, 25 (12) : 1321 - 1321
  • [10] Intra-individual variation in serum type I procollagen carboxy-terminal propeptide and type I collagen carboxy-terminal cross-linked telopeptide concentrations
    Stevenson, HP
    Leslie, H
    Sheridan, B
    ANNALS OF CLINICAL BIOCHEMISTRY, 1997, 34 : 317 - 318
12345